Compounded peptides and medications
A compounded medication is prepared by a licensed pharmacy for an individual prescription rather than manufactured in a factory. It's how providers prescribe compounded peptides and other molecules that have no commercial version and adjust formulations to a patient — and it comes with its own rules: compounded medications are not FDA-approved, and quality depends on the pharmacy's standards.
These articles explain how compounding works, how it's regulated, and what that means for the treatments you're prescribed.
325 articles on this topic
-
What Are Peptides? A Plain-English Guide
Peptides are short chains of amino acids that the body uses as signals. The same broad family includes natural hormones, established medicines and experimental compounds, so the name alone says little about evidence or safety.
-
DSIP Side Effects: What Human Studies Found
Reported DSIP side effects include sleep pressure, headache, nausea, vertigo, sweating and occasional blood-pressure changes, but small, short studies leave long-term risk largely unknown.
-
How Long Does BPC-157 Take to Work?
No human trial establishes a reliable BPC-157 onset. Animal studies measured changes from day 1 through several weeks, but a prescribed course is judged by the specific outcome and follow-up—not a promised start day.
-
PT-141 for Men: What the Male Studies Show
PT-141 produced measurable erectile responses in early male trials, including studies involving men who reported an inadequate response to sildenafil. The evidence is limited, route-specific, and not the same as an established male indication.
-
Semaglutide Drug Interactions: What Matters
Most semaglutide interactions are not classic liver-enzyme conflicts. The practical concerns are low blood sugar with insulin or sulfonylureas and altered absorption of oral medicines that need tightly controlled exposure.
-
Tesamorelin for Belly Fat: What the Studies Show
Tesamorelin has reduced visceral abdominal fat in randomized trials, most convincingly in adults with HIV-associated lipodystrophy. That evidence does not make it a general weight-loss drug or a reliable way to shrink the fat just under the skin.
-
Is Semaglutide FDA Approved? Not When Compounded
Semaglutide prescribed through Promise is dispensed by a licensed U.S. compounding pharmacy as a compounded medication, which is different from an FDA-approved product: the formulation offered here is not FDA-approved. Ozempic, Rybelsus and Wegovy have approvals for specific uses.
-
KLOW vs GLOW: What KPV Adds to the Blend
KLOW and GLOW share BPC-157, TB-500, and GHK-Cu; KLOW adds KPV, an inflammation-focused tripeptide backed by cell and mouse studies—not blend-level human trials.
-
NAD Injection Dosage: What Human Studies Used
There is no validated subcutaneous or intramuscular NAD+ schedule. The best-known IV pharmacokinetic study used 750 mg over six hours, so a prescriber must set route, concentration, amount and frequency together.
-
Semaglutide and Pregnancy: What the Evidence Says
Semaglutide is not recommended for routine weight management during pregnancy. The label calls for a two-month gap before planned conception, while early human exposure data remain limited rather than conclusive.
-
Tesamorelin vs Ipamorelin: What Sets Them Apart
Both peptides signal the pituitary to release growth hormone, but they use different receptors and carry very different levels of human evidence. Tesamorelin has phase 3 trial data; ipamorelin does not.
-
BPC-157 for Tendonitis: What the Evidence Shows
The tendon case for BPC-157 comes from cells and rats, not randomized human trials. Here is what those studies can tell us, what they cannot, and why rehabilitation still matters.
-
Is NAD a Peptide? What NAD+ Actually Is
NAD+ is a dinucleotide coenzyme, not a peptide. Its chemistry, cellular jobs, and evidence are different from the peptide therapies it often appears beside.
-
Is Tirzepatide FDA Approved? Not When Compounded
Tirzepatide has branded approvals under Mounjaro and Zepbound. A compounded preparation is different from an FDA-approved product: the formulation offered here is not FDA-approved.
-
Peptides for Muscle Growth: Evidence and Limits
Prescription GH-axis peptides can change hormone levels and, in selected patients, body composition. Human evidence does not show that they produce hypertrophy or greater strength in healthy trained adults.
-
Sermorelin for Women: Evidence and Menopause
Sermorelin can raise growth-hormone output in women when the pituitary responds, but female-specific trials are small and mostly use related GHRH compounds. It is not menopause hormone therapy, and the evidence does not show reliable gains in sleep, libido or lean mass for women.
-
Are Peptides Legal in the US? What the Law Says
Prescription peptides can be lawful when a licensed provider prescribes them and an authorized pharmacy dispenses them under federal and state rules. A compounded medication, an approved drug and a grey-market vial do not share the same legal status.
-
Epitalon Dosage: How a Prescriber Decides
Published evidence does not establish a standard dose. One small human AEDG study used 0.5 mg daily under the tongue for 20 days; injection-cycle numbers often come from animal work or studies of a different pineal extract.
-
How to Store Peptides: Fridge, Freezer, and Travel
Reconstituted peptide vials are commonly refrigerated at 2–8 °C, but the pharmacy label and beyond-use date always control. Lyophilized powders and commercial pens may have different limits.
-
Oral BPC-157: Do Capsules Work?
Oral activity has been reported in rat gut models, but capsules have not been tested in human trials and their absorption in people has not been measured. A capsule label cannot close that evidence gap.
Page 14 of 17 · 325 articles